Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation
Authors:
- 1 August 2009
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1791 (8) , 730-739
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signalingEuropean Journal of Cell Biology, 2009
- Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathwayJournal of Cell Biology, 2008
- Sphingosine kinase‐1 is cleaved by cathepsin B in vitro: Identification of the initial cleavage sites for the proteaseFEBS Letters, 2006
- Sphingolipid targets in cancer therapyMolecular Cancer Therapeutics, 2006
- Ceramidase Regulates Synaptic Vesicle Exocytosis and TraffickingJournal of Neuroscience, 2004
- Biologically active sphingolipids in cancer pathogenesis and treatmentNature Reviews Cancer, 2004
- Nitric Oxide Induces Degradation of the Neutral Ceramidase in Rat Renal Mesangial Cells and Is Counterregulated by Protein Kinase CJournal of Biological Chemistry, 2002
- Neutral/Alkaline and Acid Ceramidase Activities Are Actively Released by Murine Endothelial CellsBiochemical and Biophysical Research Communications, 2000
- Differential Regulation of Sphingomyelinase and Ceramidase Activities by Growth Factors and CytokinesJournal of Biological Chemistry, 1995
- Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signalsCell, 1995